Jortek Surgical, Inc. – Trademark Portfolio

Entity Type: 03

Jortek Surgical, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 8 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include JORTEK, ORTHOMI, NOTCHLOK, TENOSURE, and ANATOMACL. The owner is based in Boulder, CO.

2335 Panorama Ave.

Boulder, CO 80304

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TENOSURE
TENOSURE
Registered 2020
ORTHOMI
ORTHOMI
Registered 2017
NOTCHLOK
NOTCHLOK
Registered 2017
TENOSURE
TENOSURE
Abandoned 2016
ANATOMACL
ANATOMACL
Registered 2015
JORTEK
JORTEK
Registered 2014
JORTEK
JORTEK
Abandoned 2010

Trademark Classifications

Jortek Surgical, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (8 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Jortek Surgical, Inc. have?

Jortek Surgical, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 abandoned.

What trademark classes does Jortek Surgical, Inc. file in?

Jortek Surgical, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Jortek Surgical, Inc.'s most well-known trademarks?

Jortek Surgical, Inc.'s registered trademark portfolio includes well-known marks such as JORTEK, ORTHOMI, NOTCHLOK, TENOSURE, and ANATOMACL. These are among 5 currently registered trademarks in the portfolio.

What is Jortek Surgical, Inc.'s trademark registration success rate?

Jortek Surgical, Inc. has a 63% trademark registration rate, with 5 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.